CDK6-STXBP6 Fusion FISH Probe
The CDK6-STXBP6 Fusion FISH Probe is used to confirm a fusion of the CDK6 and STXBP6 genes. The fusion of the CDK6 and STXBP6 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CDK6-STXBP6-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CDK6-STXBP6-20-AQAQ | 20 (40 μL) | 200 μL |
|
CDK6 Gene Summary
The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
Gene Name: Cyclin Dependent Kinase 6
Chromosome: CHR7: 92234234 -92465941
Locus: 7q21.2
STXBP6 Gene Summary
STXBP6 binds components of the SNARE complex (see MIM 603215) and may be involved in regulating SNARE complex formation (Scales et al., 2002 [PubMed 12145319]).[supplied by OMIM, Mar 2008]
Gene Name: Syntaxin Binding Protein 6
Chromosome: CHR14: 25281305 -25519095
Locus: 14q12
Gene Diseases
The CDK6 STXBP6 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|